These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9454763)

  • 1. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases.
    Fressinaud E; Veyradier A; Truchaud F; Martin I; Boyer-Neumann C; Trossaert M; Meyer D
    Blood; 1998 Feb; 91(4):1325-31. PubMed ID: 9454763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
    Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
    Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
    Favaloro EJ; Facey D; Henniker A
    Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-shear force-induced platelet aggregation in the screening and diagnosis of von Willebrand disease].
    Schlammadinger A; Kerényi A; Muszbek L; Boda Z
    Orv Hetil; 2000 Oct; 141(41):2245-50. PubMed ID: 11184249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
    Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
    Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease.
    Cattaneo M; Federici AB; Lecchi A; Agati B; Lombardi R; Stabile F; Bucciarelli P
    Thromb Haemost; 1999 Jul; 82(1):35-9. PubMed ID: 10456451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time.
    Podda GM; Bucciarelli P; Lussana F; Lecchi A; Cattaneo M
    J Thromb Haemost; 2007 Dec; 5(12):2393-8. PubMed ID: 18034764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Platelet Function Analyser (PFA-100) in patients with a bleeding tendency.
    Wuillemin WA; Gasser Ka; Zeerleder SS; Lämmle B
    Swiss Med Wkly; 2002 Aug; 132(31-32):443-8. PubMed ID: 12457302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates.
    Fressinaud E; Veyradier A; Sigaud M; Boyer-Neumann C; Le Boterff C; Meyer D
    Br J Haematol; 1999 Sep; 106(3):777-83. PubMed ID: 10468873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and vWF:CBA as combined diagnostic strategies.
    Favaloro EJ; Kershaw G; Bukuya M; Hertzberg M; Koutts J
    Haemophilia; 2001 Mar; 7(2):180-9. PubMed ID: 11260278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of platelet function analyzer as a screening tool for the diagnosis of von Willebrand disease in adolescents with menorrhagia.
    Naik S; Teruya J; Dietrich JE; Jariwala P; Soundar E; Venkateswaran L
    Pediatr Blood Cancer; 2013 Jul; 60(7):1184-7. PubMed ID: 23335259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the platelet function analyser (PFA-100) in the characterization of patients with von Willebrand's disease and its relationships with von Willebrand factor and the ABO blood group.
    Nitu-Whalley IC; Lee CA; Brown SA; Riddell A; Hermans C
    Haemophilia; 2003 May; 9(3):298-302. PubMed ID: 12694521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
    Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
    Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction.
    Harrison P; Robinson M; Liesner R; Khair K; Cohen H; Mackie I; Machin S
    Clin Lab Haematol; 2002 Aug; 24(4):225-32. PubMed ID: 12181026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
    Castaman G; Tosetto A; Goodeve A; Federici AB; Lethagen S; Budde U; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Ingerslev J; Habart D; Hill F; Peake I; Rodeghiero F
    Br J Haematol; 2010 Nov; 151(3):245-51. PubMed ID: 20738304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system.
    Di Paola J; Federici AB; Mannucci PM; Canciani MT; Kritzik M; Kunicki TJ; Nugent D
    Blood; 1999 Jun; 93(11):3578-82. PubMed ID: 10339461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease.
    Buyukasik Y; Karakus S; Goker H; Haznedaroglu IC; Ozatli D; Sayinalp N; Ozcebe OI; Dundar SV; Kirazli S
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):349-53. PubMed ID: 12032401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PFA-100 system: a new method for assessment of platelet dysfunction.
    Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
    Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Jul; 32(5):537-45. PubMed ID: 16862528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.